Tag Archives: diet-drug
What the Fuss Orexign Therapeutics, Northern Oil & Gas and AMR Corp.?
In this report: Orexign Therapeutics (NASDAQ:OREX), Northern Oil and Gas (NYSE:NOG) and AMR Corp.(NYSE:AMR).
Orexign Therapeutics (NASDAQ:OREX) jumped more than 50 percent on Wednesday after it was announced that it would go to the Food and Drug Administration to get …
Posted in Latest Headlines, Reports
|
Tagged American Airlines, AMR, AMR Corp., approval, barrels, cardiovascular, Chad Mabry, clinical data, costs, diet-drug, drugs, Energy, FDA, flights, Food and Drug Administration, forecasting, fuel, Hurricane Irene, management, NASDAQ:OREX, NOG, Northern Oil and Gas, NYSE:AMR, NYSE:NOG, Oil, OREX, Orexign Therapeutics, outlook, price target, prices, profitable, quarter, rally, regulators, reserves, revenue, risks, Rodman & Renshaw, Wall Street
|
Comments Off
















